Carlton Haywood

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Attitudes toward clinical trials among patients with sickle cell disease
    Carlton Haywood
    Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA
    Clin Trials 11:275-283. 2014
  2. doi request reprint Improving Clinician Attitudes of Respect and Trust for Persons With Sickle Cell Disease
    Carlton Haywood
    The Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland and
    Hosp Pediatr 5:377-84. 2015
  3. pmc Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease
    Carlton Haywood
    The Johns Hopkins School of Medicine, Baltimore, Maryland, USA Electronic address
    J Pain Symptom Manage 48:934-43. 2014
  4. pmc Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease
    Carlton Haywood
    The Johns Hopkins School of Medicine, Baltimore, MD, USA
    J Gen Intern Med 29:1657-62. 2014
  5. pmc An unequal burden: poor patient-provider communication and sickle cell disease
    Carlton Haywood
    Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, USA Electronic address
    Patient Educ Couns 96:159-64. 2014
  6. pmc The impact of race and disease on sickle cell patient wait times in the emergency department
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    Am J Emerg Med 31:651-6. 2013
  7. ncbi request reprint A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
    Carlton Haywood
    Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Division of Hematology, 2024 E Monument St, Rm 2 521, Baltimore, MD 21287, USA
    J Natl Med Assoc 101:1022-33. 2009
  8. doi request reprint Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA
    Pediatrics 122:1332-42. 2008
  9. pmc Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Am J Hematol 86:85-7. 2011
  10. pmc Religious coping and hospital admissions among adults with sickle cell disease
    Shawn M Bediako
    Department of Psychology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
    J Behav Med 34:120-7. 2011

Collaborators

Detail Information

Publications36

  1. pmc Attitudes toward clinical trials among patients with sickle cell disease
    Carlton Haywood
    Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA
    Clin Trials 11:275-283. 2014
    ..A substantial number of planned clinical trials for sickle cell disease (SCD) have terminated early due to insufficient patient enrollment...
  2. doi request reprint Improving Clinician Attitudes of Respect and Trust for Persons With Sickle Cell Disease
    Carlton Haywood
    The Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland and
    Hosp Pediatr 5:377-84. 2015
    ..To test the effect of 1 high-intensity, and 1 reduced-intensity, educational intervention designed to improve health care provider attitudes toward youth with sickle cell disease (SCD)...
  3. pmc Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease
    Carlton Haywood
    The Johns Hopkins School of Medicine, Baltimore, Maryland, USA Electronic address
    J Pain Symptom Manage 48:934-43. 2014
    ..Perceived discriminatory experiences in society have been associated with a higher burden of pain among some minority patient populations...
  4. pmc Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease
    Carlton Haywood
    The Johns Hopkins School of Medicine, Baltimore, MD, USA
    J Gen Intern Med 29:1657-62. 2014
    ..Adults with sickle cell disease (SCD) report experiencing discriminatory behavior from some healthcare providers. The impact of discrimination on health outcomes in SCD, including adherence to physician recommendations, is not known...
  5. pmc An unequal burden: poor patient-provider communication and sickle cell disease
    Carlton Haywood
    Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, USA Electronic address
    Patient Educ Couns 96:159-64. 2014
    ..To assess disparities in the quality of healthcare provider communication experienced by African-American adults with and without sickle cell disease (SCD) in the U.S...
  6. pmc The impact of race and disease on sickle cell patient wait times in the emergency department
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    Am J Emerg Med 31:651-6. 2013
    ....
  7. ncbi request reprint A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease
    Carlton Haywood
    Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University School of Medicine, Division of Hematology, 2024 E Monument St, Rm 2 521, Baltimore, MD 21287, USA
    J Natl Med Assoc 101:1022-33. 2009
    ....
  8. doi request reprint Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
    John J Strouse
    Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA
    Pediatrics 122:1332-42. 2008
    ..Hydroxyurea is the only approved medication for the treatment of sickle cell disease in adults; there are no approved drugs for children...
  9. pmc Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
    Carlton Haywood
    Department of Medicine, Division of Hematology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA
    Am J Hematol 86:85-7. 2011
    ..A deeper understanding of patient perspectives toward HU utilization is required as part of multipronged efforts to combat its underutilization in the treatment of SCD...
  10. pmc Religious coping and hospital admissions among adults with sickle cell disease
    Shawn M Bediako
    Department of Psychology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
    J Behav Med 34:120-7. 2011
    ..29, P < .05). These results indicate a need for further investigation of the roles that religion and spirituality play in adjustment to sickle cell disease and their influence on health care utilization patterns and health outcomes...
  11. pmc The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization
    C Patrick Carroll
    Department of Psychiatry Behavioral Sciences, The Johns Hopkins School of Medicine, USA
    Am J Hematol 84:666-70. 2009
    ..Despite this, a small subpopulation engaged in exceptional levels of inpatient utilization over multiple years...
  12. pmc Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care
    Carlton Haywood
    Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Hosp Med 5:289-94. 2010
    ....
  13. pmc A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 26:518-23. 2011
    ..Negative attitudes toward adults with sickle cell disease have been identified as an important barrier to the receipt of appropriate pain management for this patient population...
  14. pmc Multiple Levels of Suffering: Discrimination in Health-Care Settings is Associated With Enhanced Laboratory Pain Sensitivity in Sickle Cell Disease
    Vani A Mathur
    Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, MD Texas A and M University, Department of Psychology, College Station, TX Johns Hopkins University School of Medicine, Division of Hematology University of Maryland, Baltimore County, Department of Psychology, Baltimore, MD Harvard Medical School, Departments of Anesthesiology, Perioperative, Pain Medicine, and Psychiatry Brigham and Women s Hospital, Pain Management Center, Harvard Medical School, Chestnut Hill, MA
    Clin J Pain 32:1076-1085. 2016
    ..In this particularly relevant context, we examined the relationship between perceived discrimination and both clinical and laboratory pain...
  15. pmc Improving Emergency Providers' Attitudes Toward Sickle Cell Patients in Pain
    Aditi Puri Singh
    Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA Electronic address
    J Pain Symptom Manage 51:628-32.e3. 2016
    ..Provider biases and negative attitudes are recognized barriers to optimal pain management in sickle cell disease, particularly in the emergency department (ED)...
  16. doi request reprint Primary Care Providers' Comfort Levels in Caring for Patients with Sickle Cell Disease
    Lauren N Whiteman
    From the Departments of Medicine and Pediatrics, and the Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland
    South Med J 108:531-6. 2015
    ..The purpose of this study was to determine the comfort levels of primary care providers in caring for individuals with sickle cell disease (SCD) and determine factors that improved or lessened provider comfort...
  17. pmc Effect of Free Dental Services on Individuals with Sickle Cell Disease
    Lauren N Whiteman
    From the Departments of Medicine, Pediatrics, and Otolaryngology, and the Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland
    South Med J 109:576-8. 2016
    ..Because the majority of individuals with SCD have Medicaid insurance and no dental coverage, we provided free basic dental care to individuals with SCD to determine whether it decreased overall healthcare utilization...
  18. pmc Measuring and explaining racial and ethnic differences in willingness to donate live kidneys in the United States
    Tanjala S Purnell
    Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Clin Transplant 27:673-83. 2013
    ..Reasons for US racial-ethnic minority ESRD patients' reported difficulties identifying live kidney donors are poorly understood...
  19. ncbi request reprint Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Natl Med Assoc 100:968-73. 2008
    ..006). The results of this survey suggest that lack of awareness, agreement and belief in the benefits of hydroxyurea contributes to providers underprescribing hydroxyurea...
  20. doi request reprint Examining the effectiveness of hydroxyurea in people with sickle cell disease
    Sophie Lanzkron
    Div of Hematology, Dept of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 7300, Baltimore, MD 21205, USA
    J Health Care Poor Underserved 21:277-86. 2010
    ..2,017, p=.031). Hydroxyurea was underutilized in this patient population. Patients with more regular refills of hydroxyurea had fewer admissions to the hospital and markedly decreased costs...
  21. pmc Utility of the Montreal Cognitive Assessment as a Screening Test for Neurocognitive Dysfunction in Adults with Sickle Cell Disease
    Cody Cichowitz
    From the Departments of Psychiatry and Behavioral Medicine, Pediatrics, and Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, and the Division of Hematology, Duke University School of Medicine, Durham, North Carolina
    South Med J 109:560-5. 2016
    ..The purpose of this study was to evaluate the Montreal Cognitive Assessment (MoCA) as a screening tool and identify predictors of MoCA performance in adults with sickle cell disease...
  22. pmc Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls
    Claudia M Campbell
    aDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA bDivision of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA cHarvard Medical School, Departments of Anesthesiology, Perioperative, Pain Medicine, and Psychiatry, Brigham and Women s Hospital, Pain Management Center, Chestnut Hill, MA, USA dDepartment of Acute and Chronic Care, Johns Hopkins University School of Nursing, Baltimore, MD, USA
    Pain 157:949-56. 2016
    ..Future research is warranted to evaluate the impact of enhanced pain-related cytokine response and whether it is predictive of clinical characteristics and the frequency/severity of pain crises in patients with SCD...
  23. pmc The impact of depressive symptoms on patient-provider communication in HIV care
    Charles R Jonassaint
    a Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD, USA
    AIDS Care 25:1185-92. 2013
    ..These negative attitudes may ultimately serve to adversely impact patient-provider communication and quality of HIV care. ..
  24. pmc Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication
    Rakhi P Naik
    Department of Medicine, Division of Hematology, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Med 126:443-9. 2013
    ..The purpose of this study was to establish the prevalence and risk factors for venous thromboembolism in a large cohort of patients with sickle cell disease and determine the relationship between venous thromboembolism and mortality...
  25. pmc Mortality rates and age at death from sickle cell disease: U.S., 1979-2005
    Sophie Lanzkron
    Johns Hopkins School of Medicine, Department of Medicine, Baltimore, MD 21205, USA
    Public Health Rep 128:110-6. 2013
    ..Whether similar improvements for adults with the disease have occurred is unknown. We investigated mortality rates for children and adults with SCD...
  26. pmc The association of provider communication with trust among adults with sickle cell disease
    Carlton Haywood
    Division of Hematology, The Johns Hopkins University School of Medicine, The Johns Hopkins Berman Institute of Bioethics, Baltimore, MD 21205, USA
    J Gen Intern Med 25:543-8. 2010
    ..Adults with sickle cell disease often report poor interpersonal healthcare experiences, including poor communication with providers. However, the effect of these experiences on patient trust is unknown...
  27. doi request reprint Prediction of onset and course of high hospital utilization in sickle cell disease
    C Patrick Carroll
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Hosp Med 6:248-55. 2011
    ..Although sickle cell disease (SCD) patients typically manage their pain at home, a small subgroup is frequently hospitalized and accounts for the majority of costs...
  28. pmc Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD
    Tiffany Yu
    From the School of Medicine, University of Maryland, Baltimore, The School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, and the Departments of Medicine, Psychiatry and Behavioral Sciences, Oncology, and Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, and the Division of Hematology, Duke University School of Medicine, Durham, North Carolina
    South Med J 109:519-24. 2016
    ..We sought to clarify whether AVN independently predicts acute care utilization in adults with SCD and to identify characteristics of those with AVN that predict higher utilization...
  29. doi request reprint Quality improvement process in a sickle cell infusion center
    Lauren N Whiteman
    Department of Medicine, Johns Hopkins University, Baltimore, Md Electronic address
    Am J Med 128:541-4. 2015
    ..We examined factors affecting achievement of this standard at the Johns Hopkins Sickle Cell Infusion Center...
  30. pmc Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis
    Sophie Lanzkron
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
    Am J Hematol 90:376-80. 2015
    ..The SCIC model provides adults with SCD access to high quality care that decreases the need for hospital admission. Further research needs to be done to evaluate the cost effectiveness of this model...
  31. pmc Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
    Sophie Lanzkron
    School of Medicine, Johns Hopkins University, 1830 East Monument Street, Suite 7300, Baltimore, MD 21205, USA
    Ann Intern Med 148:939-55. 2008
    ..Hydroxyurea is the only approved drug for treatment of sickle cell disease...
  32. pmc A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients
    Patrick C Carroll
    Department of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, MA, USA
    Clin J Pain 29:317-23. 2013
    ..To identify demographic, medical, and psychosocial characteristics that distinguished sickle cell disease (SCD) patients who were frequent utilizers of urgent or emergent care resources from low-utilizing patients...
  33. pmc Patient reactions to personalized medicine vignettes: an experimental design
    Morgan Butrick
    Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21202, USA
    Genet Med 13:421-8. 2011
    ..This study describes patient responses to hypothetical conventional, race-based, or genetically personalized medicine prescriptions...
  34. doi request reprint Examination of the Patient and Hospitalization Characteristics of 30-Day SCD Readmissions
    C Patrick Carroll
    From the Departments of Psychiatry and Behavioral Sciences and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
    South Med J 109:583-7. 2016
    ..At Johns Hopkins Hospital, as at other institutions, SCD accounts for a large proportion of readmissions. Our study examined patient and hospitalization factors involved in readmissions at Johns Hopkins Hospital...
  35. pmc Sickle cell trait diagnosis: clinical and social implications
    Rakhi P Naik
    Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD and
    Hematology Am Soc Hematol Educ Program 2015:160-7. 2015
    ..The historical background of SCD and SCT has provided lessons about how research should be conducted in the modern era to minimize stigmatization, optimize study conclusions, and inform genetic counseling and policy decisions for SCT. ..
  36. doi request reprint The five key things you need to know to manage adult patients with sickle cell disease
    Sophie Lanzkron
    Johns Hopkins School of Medicine, Baltimore, MD
    Hematology Am Soc Hematol Educ Program 2015:420-5. 2015
    ..The topics that will be addressed include chronic pain, neurocognitive dysfunction, renal disease, venous thromboembolism, and avoiding the inappropriate use of red cell transfusions. ..